<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://novapharmanews.com/eu/news/european-commission-approves-jascayd-nerandomilast-ipf-ppf</loc>
    <lastmod>2026-07-21T21:03:38.017Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>NovaPharmaNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-19T21:17:52.594Z</news:publication_date>
      <news:title>JASCAYD (nerandomilast) Wins EU Approval for IPF &amp; PPF</news:title>
      <news:keywords>nerandomilast, JASCAYD, Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://novapharmanews.com/uploads/articles/european-commission-approves-jascayd-nerandomilast-ipf-ppf.webp</image:loc>
      <image:title>JASCAYD (nerandomilast) Wins EU Approval for IPF &amp; PPF</image:title>
    </image:image>
  </url>
</urlset>